Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Bicycle Therapeutics

11 Disclosed Funding Rounds $167,936,711

0 Participating Investments


Therapeutics, Medical Device, Biotechnology

Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.

Cambridge, Cambridgeshire, United Kingdom, Europe (GB)

Organizations in Cambridge in Therapeutics,
Organizations in Cambridge in Medical Device,
Organizations in Cambridge in Biotechnology,
Organizations in Cambridgeshire in Therapeutics,
Organizations in Cambridgeshire in Medical Device,
Organizations in Cambridgeshire in Biotechnology,
Organizations in United Kingdom in Therapeutics,
Organizations in United Kingdom in Medical Device,
Organizations in United Kingdom in Biotechnology,
Organizations in Europe in Therapeutics,
Organizations in Europe in Medical Device,
Organizations in Europe in Biotechnology

Investors in Cambridge in Therapeutics,
Investors in Cambridge in Medical Device,
Investors in Cambridge in Biotechnology,
Investors in Cambridgeshire in Therapeutics,
Investors in Cambridgeshire in Medical Device,
Investors in Cambridgeshire in Biotechnology,
Investors in United Kingdom in Therapeutics,
Investors in United Kingdom in Medical Device,
Investors in United Kingdom in Biotechnology,
Investors in Europe in Therapeutics,
Investors in Europe in Medical Device,
Investors in Europe in Biotechnology

Founded date 01, 2009

Founders Christian Heinis, Gregory Winter

Operating Status Active

Funding Stage IPO

Last Funding Type Debt Financing

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Date Round Raised Lead
October, 01, 2020 Debt Financing $50,000,000 -------
December, 01, 2018 Series B $27,900,000 -------
January, 04, 2018 Grant Undisclosed Innovate UK
June, 01, 2017 Series B $52,000,000 Vertex Ventures
October, 03, 2016 Series A Undisclosed -------
March, 10, 2016 Series A Undisclosed -------
October, 14, 2014 Series A $32,000,000 -------
December, 10, 2012 Venture - Series Unknown $6,027,000 -------
April, 29, 2010 Seed Undisclosed -------
October, 06, 2009 Seed Undisclosed -------
March, 11, 2008 Grant $9,709 Venture Kick

Bicycle Therapeutics Investors (35)

Investor Lead? Round Participating Raise Date Partners
Hercules Capital, Inc. No Debt Financing $50,000,000 October, 01, 2020 -------
Vertex Ventures No Series B $27,900,000 December, 01, 2018 -------
Ahren Innovation Capital No Series B $27,900,000 December, 01, 2018 -------
Cambridge Innovation Capital No Series B $27,900,000 December, 01, 2018 -------
Tybourne Capital Management No Series B $27,900,000 December, 01, 2018 -------
Innovate UK Yes Grant Undisclosed January, 04, 2018 -------
Longwood Fund No Series B $52,000,000 June, 01, 2017 -------
Cambridge Innovation Capital No Series B $52,000,000 June, 01, 2017 -------
Vertex Ventures HC No Series B $52,000,000 June, 01, 2017 -------
SR One No Series B $52,000,000 June, 01, 2017 -------
SV Health Investors No Series B $52,000,000 June, 01, 2017 -------
Novartis Venture Fund No Series B $52,000,000 June, 01, 2017 -------
Atlas Venture No Series B $52,000,000 June, 01, 2017 -------
Vertex Ventures Yes Series B $52,000,000 June, 01, 2017 -------
Ahren Innovation Capital No Series B $52,000,000 June, 01, 2017 -------
Ahren Innovation Capital No Series B $52,000,000 June, 01, 2017 -------
SR One No Series A Undisclosed October, 03, 2016 -------
SV Health Investors No Series A Undisclosed October, 03, 2016 -------
SV Health Investors No Series A Undisclosed March, 10, 2016 -------
Novartis Venture Fund No Series A $32,000,000 October, 14, 2014 -------
SR One No Series A $32,000,000 October, 14, 2014 -------
SV Health Investors No Series A $32,000,000 October, 14, 2014 -------
Atlas Venture No Series A $32,000,000 October, 14, 2014 -------
Astellas Venture Management No Series A $32,000,000 October, 14, 2014 -------
Syndicate No Series A $32,000,000 October, 14, 2014 -------
Novartis Venture Fund No Venture - Series Unknown $6,027,000 December, 10, 2012 -------
SR One No Venture - Series Unknown $6,027,000 December, 10, 2012 -------
SV Health Investors No Venture - Series Unknown $6,027,000 December, 10, 2012 -------
Atlas Venture No Venture - Series Unknown $6,027,000 December, 10, 2012 -------
Astellas Venture Management No Venture - Series Unknown $6,027,000 December, 10, 2012 -------
SV Health Investors No Seed Undisclosed April, 29, 2010 -------
SR One No Seed Undisclosed April, 29, 2010 -------
Atlas Venture No Seed Undisclosed October, 06, 2009 -------
Novartis Venture Fund No Seed Undisclosed October, 06, 2009 -------
Venture Kick Yes Grant $9,709 March, 11, 2008 -------